← Back to headlines
Rocket Pharmaceuticals (RCKT) Boosted by FDA Approval of KRESLADI
Rocket Pharmaceuticals (RCKT) has seen a commercial boost following the FDA's approval of its drug KRESLADI.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Philippines Celebrates 32 Years of Internet Connectivity, Vows Expansion
just now
LG Innotek Partners with US Software Firm Applied Intuition for Physical AI
4m ago
Astronauts to Fly Around the Moon with Expensive Toilet
34m ago
OnlyFans Model and Twitch Streamer Natalia Mogollon on Extraordinary Artist Visa in US
41m ago